Zobrazeno 1 - 10
of 12 520
pro vyhledávání: '"Diabetes Mellitus"'
Publikováno v:
Langmann, F, Ibsen, D B, Tjønneland, A, Olsen, A, Overvad, K & Dahm, C C 2023, ' Adherence to the EAT-Lancet diet is associated with a lower risk of type 2 diabetes : the Danish Diet, Cancer and Health cohort ', European Journal of Nutrition, vol. 62, no. 3, pp. 1493-1502 . https://doi.org/10.1007/s00394-023-03090-3
PURPOSE: Type 2 diabetes is a global health problem. While a healthy diet lowers risk of type 2 diabetes, less is known about diets with low climate impact. This study aimed to investigate adherence to the EAT-Lancet diet and risk of type 2 diabetes
Autor:
Seko, Yuya, Kawanaka, Miwa, Fujii, Hideki, Iwaki, Michihiro, Hayashi, Hideki, Toyoda, Hidenori, Oeda, Satoshi, Hyogo, Hideyuki, Morishita, Asahiro, Munekage, Kensuke, Kawata, Kazuhito, Yamamura, Sakura, Sawada, Koji, Maeshiro, Tatsuji, Tobita, Hiroshi, Yoshida, Yuichi, Naito, Masafumi, Araki, Asuka, Arakaki, Shingo, Kawaguchi, Takumi, Noritake, Hidenao, Ono, Masafumi, Masaki, Tsutomu, Yasuda, Satoshi, Tomita, Eiichi, Yoneda, Masato, Tokushige, Akihiro, Kamada, Yoshihiro, Takahashi, Hirokazu, Ueda, Shinichiro, Aishima, Shinichi, Sumida, Yoshio, Okanoue, Takeshi, Itoh, Yoshito, Nakajima, Atsushi, Japan Study Group of Nonalcoholic Fatty Liver Disease
Publikováno v:
Journal of Gastroenterology and Hepatology. 37:2313-2320
Older age, type 2 diabetes mellitus (T2DM), and obesity are known risk factors for liver-related events (LREs). We investigated the impacts of T2DM and obesity on LRE according to age in Japanese patients with non-alcoholic fatty liver disease (NAFLD
Publikováno v:
Current Drug Safety. 17:225-234
Background: The growing numbers of patients with diabetes mellitus in Africa and the Middle East on antidiabetic therapies necessitate an understanding of adverse event (AE) reporting in these regions. Objective: The aim of the study was to provide a
Publikováno v:
Diabetes & Metabolism Journal. 46:658-662
Sodium-glucose cotransporter 2 inhibitor (SGLT2i) and glucagon-like peptide-1 receptor agonist (GLP-1RA) are novel anti-diabetic drugs whose glucose-lowering effect and cardiovascular and renal benefits were evidenced in clinical trials. We investiga
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-11 (2019)
Scientific Reports
Scientific Reports
Type 2 diabetes mellitus (T2DM) disproportionately affects Indigenous populations. It is possible that exposure to complex mixtures of environmental contaminants contribute to T2DM development. This study examined the association between complex envi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a812301c0be3a18dd1f18aff945232ac
https://doi.org/10.32920/22782689
https://doi.org/10.32920/22782689
Publikováno v:
Gut and Liver. 16:433-442
Background/aims We investigated the effect of metabolic dysfunction-associated fatty liver disease (MAFLD) on future mortality and cardiovascular disease (CVD) using a prospective community-based cohort study. Methods Individuals from two community-b
Publikováno v:
Journal of Orthopaedic Science. 27:486-491
Background Increasingly, studies have addressed the possible association between type 2 diabetes mellitus (T2DM) and osteoarthritis (OA), although this remains an issue of controversy. Our aim in this study was to investigate the association between
Autor:
Langendoen-Gort, M, Al-Jabr, H, Hugtenburg, JG, Rutters, F, de Wit, M, Bhattacharya, D, Abu-Hanna, A, Farmer, A, Elders, PJM
Publikováno v:
Trials, 23(1):731. BioMed Central
Langendoen-Gort, M, Al-Jabr, H, Hugtenburg, J G, Rutters, F, de Wit, M, Bhattacharya, D, Abu-Hanna, A, Farmer, A & Elders, P J M 2022, ' A personalised intervention programme aimed at improving adherence to oral antidiabetic and/or antihypertensive medication in people with type 2 diabetes mellitus, the INTENSE study : study protocol for a randomised controlled trial ', Trials, vol. 23, no. 1, 731, pp. 731 . https://doi.org/10.1186/s13063-022-06491-7
Langendoen-Gort, M, Al-Jabr, H, Hugtenburg, J G, Rutters, F, de Wit, M, Bhattacharya, D, Abu-Hanna, A, Farmer, A & Elders, P J M 2022, ' A personalised intervention programme aimed at improving adherence to oral antidiabetic and/or antihypertensive medication in people with type 2 diabetes mellitus, the INTENSE study : study protocol for a randomised controlled trial ', Trials, vol. 23, no. 1, 731, pp. 731 . https://doi.org/10.1186/s13063-022-06491-7
Background Medication non-adherence is a prevalent health problem in people with type 2 diabetes mellitus (T2DM). Interventions have previously been developed to improve medication adherence, but inconsistent outcomes have been reported. A potential
Autor:
Jiaqi Guo, Heather A. Eicher-Miller, Edward J. Delp, Saul B. Gelfand, Anindya Bhadra, Elizabeth A. Richards, Marah Aqeel, Luotao Lin, Erin Hennessy
Publikováno v:
Am J Clin Nutr
Curr Dev Nutr
Curr Dev Nutr
OBJECTIVES: The aims of this study are to (1) create clusters of joint temporal patterns of diet and physical activity (PA), and (2) determine the association of these clusters with health status indicators including body mass index (BMI), waist circ
Publikováno v:
Endocrine Practice. 28:173-178
Hyperglycemia often occurs after the transition from intravenous insulin infusion (IVII) to subcutaneous insulin. Weight-based basal insulin initiated earlier in the course of IVII in the medical intensive care unit (MICU), and a weight-based basal-b